Localized Mycobacterium avium-intracellulare mastitis in an immunocompetent woman with silicone breast implants

While M. avium-intracellulare has received increasing recognition due to its association with AIDS, silicone breast implants have come under increased FDA scrutiny, requiring new safety and efficacy protocols. We report a case of localized M. avium-intracellulare mastitis associated with a breast im...

Full description

Saved in:
Bibliographic Details
Published inPlastic and reconstructive surgery (1963) Vol. 95; no. 1; p. 142
Main Authors Lee, D, Goldstein, E J, Zarem, H A
Format Journal Article
LanguageEnglish
Published United States 01.01.1995
Subjects
Adult
Breast Implants
Clarithromycin - therapeutic use
Female
Humans
Mastitis - drug therapy
Mastitis - etiology
Mastitis - immunology
Mycobacterium avium-intracellulare Infection - drug therapy
Mycobacterium avium-intracellulare Infection - etiology
Mycobacterium avium-intracellulare Infection - immunology
Mycobacterium Infections - immunology
Prosthesis Failure
Silicones
Online AccessGet more information

Cover

More Information
Summary:While M. avium-intracellulare has received increasing recognition due to its association with AIDS, silicone breast implants have come under increased FDA scrutiny, requiring new safety and efficacy protocols. We report a case of localized M. avium-intracellulare mastitis associated with a breast implant in an immunocompetent, HIV-negative woman who was cured with implant removal and a long course (6 months) of clarithromycin. Serous exudates occurring in association with breast implants should be cultured for acid-fast organisms. Clarithromycin may be a therapeutic adjunct to effectively cure these infections.
ISSN:0032-1052
DOI:10.1097/00006534-199501000-00024